# ExpressionEdits

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/expressionedits

- Industry: Biotechnology
- Headquarters: Altrincham, UK
- Website: www.expressionedits.com/
- Total disclosed funding: $13M
- Latest round: Seed (May 17, 2024)
- Investors on record: 7

## About

Based in Altrincham, UK, and founded in 2021, ExpressionEdits Ltd operates as a provider of AI-driven gene expression optimization solutions to researchers and biotechnology firms developing protein-based therapeutics. In May 2024, ExpressionEdits Ltd raised USD 13 million in seed funding co-led by Octopus Investments and Redalpine. Other new investors BlueYard Capital, Wilbe Group, Acequia Capital, Amino Collective, and Hawktail Management also participated in the round. The company provides a wide range of gene expression optimization solutions such as intronization technology, the Genetic Syntax Engine for transgene design, and AI-driven protein expression enhancement tools. Additionally, the firm also provides services such as gene therapy optimization and protein production consulting. The company plans to utilize the May 2024 funding to support the preclinical studies and protein-based therapeutics development.

## Funding rounds

- Seed, May 17, 2024, $13M — Acequia Capital, Redalpine, BlueYard Capital, Octopus Investments, Amino Collective, Hawktail, Wilbe Group

## Investors

- Acequia Capital (https://capitalatlas.ai/funds/acequia-capital) — Seed
- Redalpine (https://capitalatlas.ai/funds/redalpine) — Seed
- BlueYard Capital (https://capitalatlas.ai/funds/blueyard-capital) — Seed
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Seed
- Amino Collective (https://capitalatlas.ai/funds/amino-collective) — Seed
- Hawktail (https://capitalatlas.ai/funds/hawktail) — Seed
- Wilbe Group — Seed